CDEK
← All organizations

Apex Bioscience

For profitContributed to NME

Also known as: ApexCPG LLC | APEX GmbH | Apex Labs Ltd. | Apex Medical Research - Illinois | APEX PHARMS INC | Apex Research Institute, Santa Ana, CA 92705

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2001

First marketed drug

Dec 29, 2016

Last known activity

Oct 20, 2025

Defunct as of Oct 1, 2019

Timeline

1990s

  1. Jun 1, 1993

    Apex Bioscience— Founded

2010s

  1. Dec 29, 2016

    cyproheptadine— Marketing Organization

  2. Oct 1, 2019

    Apex Bioscience— Defunct

Drugs by trial phase (8 distinct, 8 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (8)

  • NCT07112651Lead sponsorN/AOct 20, 2025
  • NCT06141876Lead sponsorPhase 2Dec 15, 2023
  • NCT02807077Overall official - principal investigatorPhase 1Nov 1, 2014
  • NCT01819272Overall official - principal investigatorPhase 2Apr 1, 2013
  • NCT01101841Overall official - principal investigatorPhase 3Mar 1, 2010
  • NCT00907803Overall official - principal investigatorPhase 2Jun 1, 2009
  • NCT00715702Overall official - principal investigatorPhase 1Jul 1, 2008
  • NCT00021502Lead sponsorPhase 3Mar 1, 2001

Details

Founded
Durham, NC, US Jun 1, 1993
Last known activity
Oct 20, 2025